Seyed Amirhossein Tabatabaei Dakhili

FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity

Keshav Gopal, Rami Al Batran, Tariq Altamimi et al. · Cell Reports · 2021 · 65 citations · Full text

Heart Failure, Metabolic Remodeling, Insulin Signaling +20

Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

Keshav Gopal, Qutuba G. Karwi, Seyed Amirhossein Tabatabaei Dakhili et al. · Cardiovascular Diabetology · 2023 · 38 citations · Full text

SP1-independent inhibition of FOXM1 by modified thiazolidinediones

Seyed Amirhossein Tabatabaei Dakhili, David Pérez, Keshav Gopal et al. · European Journal of Medicinal Chemistry · 2020 · 25 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +7

A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactions

Seyed Amirhossein Tabatabaei Dakhili, David Pérez, Keshav Gopal et al. · Bioorganic Chemistry · 2019 · 24 citations

Medicinal Chemistry, Drug Target, Biochemistry +11

SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model Lacking Both Genes

Yongneng Zhang, Sotirios Zervopoulos, Aristeidis E. Boukouris et al. · Journal of the American Heart Association · 2021 · 15 citations · Full text